J.W. Cole Advisors Inc. lifted its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 9.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,242 shares of the company’s stock after acquiring an additional 200 shares during the quarter. J.W. Cole Advisors Inc.’s holdings in Clorox were worth $306,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Core Wealth Advisors Inc. bought a new stake in shares of Clorox during the 4th quarter worth $29,000. Innealta Capital LLC purchased a new stake in shares of Clorox in the second quarter valued at $30,000. Trifecta Capital Advisors LLC lifted its holdings in shares of Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after purchasing an additional 130 shares in the last quarter. GoalVest Advisory LLC purchased a new stake in shares of Clorox in the first quarter valued at $31,000. Finally, First Foundation Advisors purchased a new stake in shares of Clorox in the first quarter valued at $31,000. 78.53% of the stock is owned by institutional investors.
Insider Activity at Clorox
In related news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.51% of the company’s stock.
Clorox Trading Down 0.8 %
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings data on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The business had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. Equities research analysts forecast that The Clorox Company will post 6.63 earnings per share for the current year.
Clorox Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Wednesday, August 14th were paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 2.99%. This is a positive change from Clorox’s previous quarterly dividend of $1.20. The ex-dividend date was Tuesday, August 13th. Clorox’s payout ratio is currently 252.85%.
Analyst Ratings Changes
CLX has been the subject of a number of research analyst reports. Wells Fargo & Company reduced their target price on Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a report on Wednesday, July 10th. Argus upgraded Clorox to a “hold” rating in a report on Tuesday, June 4th. TD Cowen began coverage on Clorox in a report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price objective for the company. DA Davidson reiterated a “neutral” rating and set a $153.00 price objective on shares of Clorox in a report on Friday, September 6th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Six equities research analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $143.50.
Check Out Our Latest Stock Report on CLX
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- Quiet Period Expirations Explained
- How Much Can You Make in Stocks in One Month?
- What is the NASDAQ Stock Exchange?
- This Is the Top Large-Cap Stock Insiders Are Buying
- What does consumer price index measure?
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.